Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222)

Journal article

Flaxman A. et al, (2021), SSRN Electronic Journal

ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.

Journal article

Voysey M. and Pollard AJ., (2021), Lancet, 397

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.

Journal article

Madhi SA. et al, (2021), N Engl J Med

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Journal article

Emary KRW. et al, (2021), SSRN Electronic Journal

Load More